tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steve Chesney, 24 are a BUY (42.86%), 30 are a HOLD (53.57%), 2 are a SELL (3.57%).
Analyst Steve Chesney, currently employed at ATLANTIC EQUITIES, carries an average stock price target met ratio of 74.67% that have a potential upside of 28.64% achieved within 558 days.
Steve Chesney’s has documented 106 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 06-Feb-2024.
Analyst best performing recommendations are on CELG (CELGENE).
The best stock recommendation documented was for CELG (CELGENE) at 12/18/2015. The price target of $122 was fulfilled within 5 days with a profit of $11.86 (10.77%) receiving and performance score of 21.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 17-Mar-2026
$175
$-52.6 (-23.11%)
$150
17 days ago
(10-Sep-2026)
0/3 (0%)
$-40.43 (-18.77%)
Buy Since 15-May-2026
$245
$17.4 (7.64%)
$225
24 days ago
(03-Sep-2026)
5/9 (55.56%)
$20.49 (9.13%)
69
Buy Since 04-Mar-2022
$260
$32.4 (14.24%)
$240
1 months 2 days ago
(25-Aug-2026)
57/87 (65.52%)
$39.23 (17.77%)
169
Buy Since 28-Sep-2022
$241
$13.4 (5.89%)
$221
1 months 23 days ago
(04-Aug-2026)
25/42 (59.52%)
$32.55 (15.62%)
152
Hold Since 06-Jan-2023
$215
$-12.6 (-5.54%)
$200
1 months 24 days ago
(03-Aug-2026)
29/38 (76.32%)
$13.18 (6.53%)
220
What Year was the first public recommendation made by Steve Chesney?
